Fosfomycin for treatment of uncomplicated lower urinary tract infection


DOI: https://dx.doi.org/10.18565/urology.2018.5.153-158

S.H. Al-Shukri, M.N. Slesarevskaya, I.V. Kuz’min

1Department of urology Federal State Budgetary Educational Institution of Higher Education «Academician I.P. Pavlov First St. Petersburg State Medical University», Saint Petersburg, Russia; 2Scientific and Research Center of Urology in Scientific and Research Center of Surgery and Emergency Medicine Urology of Medicine Federal State Budgetary Educational Institution of Higher Education «Academician I.P. Pavlov First St. Petersburg State Medical University», Saint Petersburg, Russia
In this article the current data on using of antibacterial drug Fosfomycin for treatment of lower urinary tract infection are reviewed. The distinct features of pharmacodynamics and pharmacokinetics of fosfomycin, as well as the spectrum of its antimicrobial activity are thoroughly discussed. The current information on the resistance of uropathogens, including those that produce extended-spectrum β-lactamase, are presented.

About the Autors


Corresponding author: M.N. Slesarevskaya – Cand.Med.Sci., senior researcher at Scientific and Research Center of Urology in Scientific and Research Center of Surgery and Emergency Medicine Urology of Medicine Federal State Budgetary Educational Institution of Higher Education "Academician I.P. Pavlov First St. Petersburg State Medical University", Saint Petersburg, Russia;
e-mail: mns-1971@yandex.ru


Similar Articles


Бионика Медиа